This bidirectional regulatory mode enables GLP-1RA to not only lower blood glucose by promoting insulin secretion but also prevent excessive blood glucose fluctuations by inhibiting glucagon release (Essaouiba, 2020), perfectly matching the pathological core of “glucose metabolism imbalance” in T2DM. This evidence concerns the gene GCG and type 2 diabetes mellitus.